Genmab A (GMAB) Receivables - Net (2023 - 2025)

Genmab A's Receivables - Net history spans 3 years, with the latest figure at $1.1 billion for Q4 2025.

  • For Q4 2025, Receivables - Net rose 21.94% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 21.94%, while the annual FY2025 figure was $1.1 billion, 21.94% up from the prior year.
  • Receivables - Net reached $1.1 billion in Q4 2025 per GMAB's latest filing, up from $930.0 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $1.1 billion in Q4 2025 to a low of $743.0 million in Q4 2023.
  • Average Receivables - Net over 3 years is $935.7 million, with a median of $930.0 million recorded in 2024.
  • Peak YoY movement for Receivables - Net: increased 25.17% in 2024, then rose 21.94% in 2025.
  • A 3-year view of Receivables - Net shows it stood at $743.0 million in 2023, then rose by 25.17% to $930.0 million in 2024, then grew by 21.94% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for GMAB's Receivables - Net are $1.1 billion (Q4 2025), $930.0 million (Q4 2024), and $743.0 million (Q4 2023).